Neil Singla
Chief Medical Officer @ Latigo Biotherapeutics, Inc.
About
Dr. Neil Singla is a nationally recognized key opinion leader in analgesic protocol design and implementation. He has published extensively and is a frequent lecturer for physicians, pharmaceutical companies and medical research institutes throughout the country. For the past several years, the main focus of Dr. Singla's academic endeavors has been to analyze and understand how the inherent variability in subjective endpoint clinical trials can be minimized. He has developed novel techniques for patient education designed to minimize variability, reduce placebo response and increase effect size. Dr. Singla chairs the Clinical Trials Special Interest Group for the International Association for the Study of Pain and organized/ chaired the Conference on Analgesic Trials scientific symposium for both the IASP and the American Pain Society. Dr. Singla pioneered and developed the use of abdominoplasty as an acute postoperative pain clinical trial model; abdominoplasty is now a common pivotal soft tissue model and has played a key role in multiple new drug approvals.
United States
Pasadena
Pharmaceuticals
Pain, Therapeutic Areas, Clinical Research, Medicine, Hospitals, Translational Medicine, Clinical Development, Medical Affairs, Drug Development, Anesthesiology, Neurology, Neuroscience, Drug Discovery, Clinical Pharmacology, CRO, Biotechnology, Clinical Trials, Drug Delivery, FDA, GCP
Experience
Chief Medical Officer
Latigo Biotherapeutics, Inc.
Chairman, Clinical Trials Special Interest Group
International Association for the Study of Pain
http://www.iasp-pain.org/SIG/ClinicalTrials
Chief Scientific Officer
Lotus Clinical Research, LLC
Greater Los Angeles, California, United States
Oversaw design and conduct of pain clinical trials for Lotus Clinical Research/ Evolution Research Group, a clinical research company with 15 specialty research sites, a full-service CRO, and a scientific/ regulatory consulting firm. Acquired new pharma clients and supported existing clients with scientific guidance.
Founder and CEO
Lotus Clinical Research, LLC
Greater Los Angeles Area
2001-2021: Founded and managed a specialty clinical research company, Lotus Clinical Research. Expanded Lotus from a single hospital-based research clinic to a 100-employee organization comprised of a network of specialty research centers, a full-service CRO, and a scientific/ regulatory consulting firm. Notable innovations included pioneering the abdominoplasty postoperative pain clinical trial model for acute pain therapies, and refining/ validating the DOMS (Delayed Onset Muscle Soreness) acute pain model. Served as Investigator on over 150 clinical trials, mostly in acute and chronic pain. 2018: Spearheaded successful private equity exit to DFW Capital Partners 2019: Guided Lotus acquisition of HD Research network of specialty research sites 2021: Managed and supported private equity-backed merger with Evolution Research Group
Chairman, Clinical Trials Shared Interest Group
American Pain Society (APS)
http://americanpainsociety.org/get-involved/shared-interest-groups/clinical-tria
Education
Northeast Ohio Medical University (NEOMED)
The University of Akron
Neil Singla's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles
Find Emails
Access verified email addresses for your target contacts.
657M+ emails
Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers
More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.